Hitoshi Mochizuki

department of gastroenterology

H指数:31

被引数:3,751

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of infection timing before vaccination on the effectiveness of COVID-19 mRNA vaccine in healthcare workers

疫苗接种前感染时间对医疗保健工作者COVID-19 mRNA疫苗有效性的影响

MICROBIOLOGY SPECTRUM

IF3.8

2025-11-010

PRE

Reply to Letter to Editor “Unresolved heterogeneity in hepatic irAEs: critical limitations in prognostic interpretation for ICI-treated patients”

回复致编辑函“肝源性免疫相关不良事件中的未解决异质性：对ICI治疗患者预后解释的关键局限性”

Hepatology International

IF6.1

2025-07-080

PRE

Decoding Genomic Diversity to Guide Tumor Lesion-Specific Treatment of Multifocal Hepatocellular Carcinoma

解码基因组多样性以指导多灶性肝细胞癌病灶特异性治疗

CANCER MEDICINE

IF3.1

2025-03-270

OAAI

Profiling in advanced hepatocellular carcinoma: opening new doors for precision medicine

HEPATOLOGY INTERNATIONAL

IF6.1

2024-12-200

PRE

The efficacy of bile liquid biopsy in the diagnosis and treatment of biliary tract cancer

胆汁液活检在胆道肿瘤诊治中的应用

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES

IF2.8

2024-03-242

PRE

Changes in Viral Dynamics Following the Legal Relaxation of COVID-19 Mitigation Measures in Japan From Children to Adults: A Single Center Study, 2020-2023

INFLUENZA AND OTHER RESPIRATORY VIRUSES

IF4.2

2024-03-211

OAAI

Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer

预测卵巢癌对PARP抑制剂反应的临床和分子生物标志物

JOURNAL OF GYNECOLOGIC ONCOLOGY

IF3.7

2024-01-010

OAAI

Deep target sequencing of cytological tumor cells using whole genome amplification

ANNALS OF ONCOLOGY

IF65.4

2023-11-010

Challenges for lung cancer screening using blood samples e methylome analysis of plasma-derived cell-free DNA

ANNALS OF ONCOLOGY

IF65.4

2023-11-010

Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination

MICROBIOLOGY SPECTRUM

IF3.8

2023-06-152

OAAI

Carcinogenic potential in regenerated mucosa after endoscopic resection of esophageal squamous cell carcinoma

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2023-05-160

PRE

Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile

CANCER

IF5.1

2023-03-181

PRE

The incidence of all organ malignancies and overall survival of patient with sustained virological response of HCV-comparable to SMR (standardized mortality ratio) of Japan general population

HEPATOLOGY INTERNATIONAL

IF6.1

2023-02-221

Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis

通过基因组和微卫星分析阐明同步子宫内膜癌和卵巢癌 (SEO) 的基因组起源

JOURNAL OF GYNECOLOGIC ONCOLOGY

IF3.7

2023-01-0112

OAAI

TP53-positive clones are responsible for drug-tolerant persister and recurrence of HER2-positive breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2022-09-102

PRE

Lung Cancer Surgery With Persistent COVID-19 Infection

ANNALS OF THORACIC SURGERY

IF3.9

2022-08-013

OAAI

Direct comparison of Xpert Xpress, FilmArray Respiratory Panel, Lumipulse antigen test, and RT-qPCR in 165 nasopharyngeal swabs

BMC INFECTIOUS DISEASES

IF3

2022-03-0419

OAAI

Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling

通过基因组谱分析区分原发性肺癌和肺转移

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2021-12-015

The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection

VIRUSES-BASEL

IF3.5

2021-11-040

OAAI

Sphingomonas and Phenylobacterium as Major Microbiota in Thymic Epithelial Tumors

JOURNAL OF PERSONALIZED MEDICINE

IF3

2021-10-2618

Hitoshi Mochizuki

个人简介

教育背景

工作经历

荣誉奖项

研究方向